Senior Director, Financial Planning & Analysis

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process. Full Time Malvern, PA, US 14 days ago Requisition ID: 1008 Uniquity Bio is a clinical-stage biotechnology company committed to putting science and patients first. We exist to develop transformative new medicines for immune-mediated diseases, and we're looking for bright-minded professionals driven by a desire to advance science and make a difference for people in need. Our lead asset, solrikitug, is a highly-potent TSLP inhibitor now in Phase 2 clinical trials for asthma, chronic obstructive pulmonary disease (COPD), and eosinophilic esophagitis (EoE) indications. Join us in building an organization where people and science thrive together. You'll have the opportunity to make a meaningful impact while working alongside a talented, agile team in an environment where ideas move quickly, colleagues are trusted, and quality remains a cornerstone. Position Overview The Senior Director, FP&A owns the corporate financial model, the long-range plan, and the analytics that inform how capital is allocated across programs. The role is the principal financial partner to R&D and Clinical Operations and a primary author of the materials the board and investors rely on. Key Responsibilities Planning and forecasting Own the annual operating plan, the quarterly reforecast, and the multi-year long-range plan. Maintain the integrated corporate model, including operating expense, headcount, capital, cash flow, and runway. Produce the monthly budget-to-actual reporting package with variance analysis and forward-looking commentary. Program and R&D finance Build and maintain program-level cost models across each clinical asset, from study design assumptions through database lock. Partner with Clinical Operations on trial budgets, CRO and vendor bid analysis, contract negotiation support, and enrollment-driven spend curves. Translate protocol and timeline changes into financial impact quickly enough to inform the decision that prompted them. Decision support and valuation Develop scenario and sensitivity analyses across development, partnering, and financing paths. Build risk-adjusted NPV, IRR, and return analyses to support portfolio prioritization and business development evaluation. Support competitive benchmarking, comparable company analysis, and market sizing in partnership with the commercial and corporate development functions. Board, investor, and sponsor reporting Prepare board and audit committee financial materials and the recurring investor and sponsor reporting package. Support diligence and financing processes, including data room preparation and management of financial information requests. Build the reporting cadence, KPI framework, and forecast discipline expected of a public company. Systems and team Own the planning system and reporting tools, including selection and implementation as the company scales. Partner with Accounting to align the chart of accounts, close outputs, and accrual estimates with planning inputs. Build and lead the FP&A function over time, beginning as an individual contributor with deep hands-on ownership. Qualifications Required Bachelor’s degree in finance, accounting, economics, or a related field. Ten or more years of progressive FP&A or corporate finance experience. Direct biotech or pharmaceutical experience, including clinical development cost modeling. Advanced financial modeling skill, with the ability to build a model that survives audit by a sophisticated reader. Demonstrated success partnering with scientific and clinical leaders who do not think in financial terms. Preferred MBA, CFA, or CPA. Investment banking, equity research, or life sciences investing background. Experience supporting an initial public offering or another significant financing. Experience with a private equity or venture sponsor and its reporting expectations. Implementation experience with a planning platform such as Adaptive, Planful, or Pigment. Other Willingness to build the analysis personally rather than delegate it. Precision in assumptions paired with clarity in presentation. Sound instinct for which questions the board will ask before the board asks them. Steady judgment in a company where timelines and data readouts can reset the plan. At Uniquity Bio, we believe every team member has an impact on the patients we aim to serve. We are a nimble team with a rigorous approach to drug development that requires collaboration and transparency to maximize value, reduce risk, and deliver meaningful, best-in-class products. We are looking for self-starters who enjoy working in a complex, collaborative environment and are motivated to bring critical new medicines to people around the world. We are a small, fast-paced organization with a talented team of in-house employees and external consultants. Candidates must be self-motivated and able to work both independently and collaboratively to achieve success and impact in our dynamic work environment. This is a U.S.-based position. Team members who live within commuting distance of our Malvern, PA location are expected to spend time in the office, and remote employees are expected to travel to an office on a regular basis. Specific details for both local and remote staff will be discussed and agreed upon on a case-by-case basis with the employee’s manager. Business travel may be required depending upon the specific needs of the position. The above job description is not intended to be all-inclusive. Requirements of the position may change from time to time based on business needs. Uniquity Bio is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. All employment decisions are based on business needs, job requirements, and individual qualifications, without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran, or disability status. #J-18808-Ljbffr Uniquity Bio, Inc.